About ICCR-Roßdorf
ICCR-Roßdorf is a company based in Rossdorf (Germany) founded in 1987 was acquired by GBA Group in September 2023. ICCR-Roßdorf offers products and services including Genetic Toxicology Testing, General Toxicology Services, Sensitization Testing, Corrosion and Irritation Testing, and Biocompatibility Testing. ICCR-Roßdorf operates in a competitive market with competitors including Concateno, Myriamed, LeyshonBanks Toxicology, Mammoth Capital Ventures and Essem Compliance, among others.
- Headquarter Rossdorf, Germany
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Iccr-Roßdorf Gmbh
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of ICCR-Roßdorf
ICCR-Roßdorf offers a comprehensive portfolio of products and services, including Genetic Toxicology Testing, General Toxicology Services, Sensitization Testing, Corrosion and Irritation Testing, and Biocompatibility Testing.
Tests for mutagenicity and genotoxicity in pharmaceuticals.
Evaluates cytotoxicity and other toxic effects.
Assesses skin sensitization using in-vitro methods.
Tests for skin and eye irritation and corrosion.
Analyzes extracts per ISO 10993-1 standards.
Funding Insights of ICCR-Roßdorf
Investors in ICCR-Roßdorf
ICCR-Roßdorf has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include GBA Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
GBA Group is recognized as a leading life sciences service provider.
|
Founded Year | Domain | Location |
Investments & Acquisitions by ICCR-Roßdorf
Financial Statements - ICCR-Roßdorf
Iccr-Roßdorf Comparisons
Competitors of ICCR-Roßdorf
ICCR-Roßdorf operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Concateno, Myriamed, LeyshonBanks Toxicology, Mammoth Capital Ventures and Essem Compliance, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Drug research and development services are provided to biopharma firms.
|
|
| domain | founded_year | HQ Location |
Provides platforms for drug discovery and testing in biotechnology and life sciences.
|
|
| domain | founded_year | HQ Location |
Offers contract research services for toxicology studies.
|
|
| domain | founded_year | HQ Location |
Mammoth Capital Ventures is a CRO specializing in toxicology services for healthcare and pharmaceutical clients.
|
|
| domain | founded_year | HQ Location |
A clinical research organization providing GLP-compliant testing for pharmaceutical and chemical industries.
|
Latest news on Iccr-Roßdorf
Frequently Asked Questions about ICCR-Roßdorf
ICCR-Roßdorf was founded in 1987.
ICCR-Roßdorf is headquartered in Rossdorf, Germany. It is registered at Rossdorf, Hesse, Germany.
Marleen Van Nuenen is the current CEO of ICCR-Roßdorf.
It is a reliable and high-quality toxicological services provider. With over three decades of experience, they offer experimental toxicological expertise to industries such as pharma, (agro)chemical, cosmetics, and medical devices. Their focus is on genotoxicity research.
ICCR-Roßdorf's top competitors include Concateno, Myriamed and LeyshonBanks Toxicology.
ICCR-Roßdorf offers Genetic Toxicology Testing, General Toxicology Services, Sensitization Testing, Corrosion and Irritation Testing, and Biocompatibility Testing.
ICCR-Roßdorf has 1 investor. Key investors include GBA Group.